Apoptosis during iron chelator-induced differentiation in F9 embryonal carcinoma cells

被引:18
作者
Tanaka, T
Satoh, T
Onozawa, Y
Kohroki, J
Itoh, N
Ishidate, M
Muto, N
Tanaka, K
机构
[1] Hiroshima Prefectural Univ, Sch Appl Biosci, Hiroshima 7270023, Japan
[2] Olympus Opt Co, Chromosome Res Ctr, Hachioji, Tokyo 1920024, Japan
[3] Osaka Univ, Grad Sch Pharmaceut Sci, Div Toxicol, Suita, Osaka 5650871, Japan
关键词
apoptosis; differentiation; embryonal carcinoma; iron chelator; retinoic acid; butyrate;
D O I
10.1006/cbir.1999.0407
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have previously demonstrated that three potent iron chelators, hinokitiol, dithizone and deferoxamine, induce differentiation of F9 embryonal carcinoma cells, as do other well-known morphogens such as retinoic acid (RA) and sodium butyrate (NaB). In this study, we compared the patterns of cell proliferation, cell death and cell cycle arrest during the process of differentiation induced by these five agents. When F9 cells were cultured with the agents at their individual differentiation-inducing concentrations, cell proliferation was rapidly inhibited by treatment with the iron chelators and NaB. In contrast, RA did not influence the rate of increase of cell number at the concentration of 1 mu M. The three chelators also caused a marked reduction in cell viability, and the treated cells exhibited internucleosomal DNA fragmentation, whereas cells treated with NaB showed no apoptotic characteristics. RA induced apoptosis weakly at 1 mu M and strongly at higher concentrations. In addition, all the iron chelators hindered cell cycle progression, resulting in an arrest at the G1-S interface or S phase. The phenomena observed in chelator-treated cells were considerably different from those in RA- or NaB-treated cells. It is concluded that the three iron chelators cause both severe apoptotic cell death and cell cycle arrest of proliferating F9 cells via cellular iron deprivation, and that this apoptotic change may be independent of the process of differentiation. (C) 1999 Academic Press.
引用
收藏
页码:541 / 550
页数:10
相关论文
共 36 条
[1]   APOPTOSIS DURING RETINOIC ACID-INDUCED DIFFERENTIATION OF F9 EMBRYONAL CARCINOMA-CELLS [J].
ATENCIA, R ;
GARCIASANZ, M ;
UNDA, F ;
ARECHAGA, J .
EXPERIMENTAL CELL RESEARCH, 1994, 214 (02) :663-667
[2]  
BERGERON RJ, 1987, CANCER RES, V47, P6010
[3]  
Burton K., 1968, Methods in Enzymology XIIB, V12, P163
[4]   RXR alpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids [J].
Clifford, J ;
Chiba, H ;
Sobieszczuk, D ;
Metzger, D ;
Chambon, P .
EMBO JOURNAL, 1996, 15 (16) :4142-4155
[5]   CONTINUOUS GROWTH AND DIFFERENTIATION OF HUMAN MYELOID LEUKEMIC-CELLS IN SUSPENSION CULTURE [J].
COLLINS, SJ ;
GALLO, RC ;
GALLAGHER, RE .
NATURE, 1977, 270 (5635) :347-349
[6]  
EASTMAN A, 1995, METHOD CELL BIOL, V46, P41
[7]   APOPTOSIS AND THE CELL-CYCLE [J].
EVAN, GI ;
BROWN, L ;
WHYTE, M ;
HARRINGTON, E .
CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (06) :825-834
[8]  
FONTECAVE M, 1992, ADV ENZYMOL, V65, P148
[9]  
GALLAGHER R, 1979, BLOOD, V54, P713
[10]   Specific induction of apoptosis in P19 embryonal carcinoma cells by retinoic acid and BMP2 or BMP4 [J].
Glozak, MA ;
Rogers, MB .
DEVELOPMENTAL BIOLOGY, 1996, 179 (02) :458-470